P

Inventor

BENCHERIF MEROUANE

US33 patents
⚠️ This page may combine multiple inventors who share the name “BENCHERIF MEROUANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TARGACEPT INC

14 patents
US6166048ADec 26, 2000

Pharmaceutical compositions for inhibition of cytokine production and secretion

TARGACEPT INC105 citations98
US6274606B1Aug 14, 2001

Methods of treating central nervous system disorders with aryl substituted olefinic amine compounds

TARGACEPT INC46 citations96
US6232316B1May 15, 2001

Methods for treatment of CNS disorders

TARGACEPT INC48 citations96
US6525065B1Feb 25, 2003

Pharmaceutical compositions and methods for effecting dopamine release

TARGACEPT INC24 citations92
US6489349B1Dec 3, 2002

Pharmaceutical compositions for inhibition of cytokine production and secretion

TARGACEPT INC31 citations92
US6218383B1Apr 17, 2001

Pharmaceutical compositions for the prevention and treatment of central nervous system disorders

TARGACEPT INC37 citations92
US7214686B2May 8, 2007

Pharmaceutical compositions and methods for effecting dopamine release

TARGACEPT INC28 citations91
US6979695B2Dec 27, 2005

Compounds capable of activating cholinergic receptors

TARGACEPT INC13 citations82
US7045538B2May 16, 2006

Compounds capable of activating cholinergic receptors

TARGACEPT INC8 citations72
US8901151B2Dec 2, 2014

Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide

TARGACEPT INC3 citations59
US9173876B2Nov 3, 2015

Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide

TARGACEPT INC1 citations58
US8846715B2Sep 30, 2014

(2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide novel salt forms, and methods of use thereof

TARGACEPT INC1 citations57
US8901177B2Dec 2, 2014

Method of treating bladder disorders

TARGACEPT INC3 citations56
US7550293B2Jun 23, 2009

Chimeric nicotinic receptor subunits

TARGACEPT INC0 citations50

(unassigned)

13 patents
US5583140ADec 10, 1996

Pharmaceutical compositions for the treatment of central nervous system disorders

181 citations99
US5861423AJan 19, 1999

Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds

119 citations98
US5952339ASep 14, 1999

Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

96 citations97
US5811442ASep 22, 1998

Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow

109 citations97
US5824692AOct 20, 1998

Pharmaceutical compositions for prevention and treatment of central nervous system disorders

67 citations96
US5604231AFeb 18, 1997

Pharmaceutical compositions for prevention and treatment of ulcerative colitis

329 citations96
US5510355AApr 23, 1996

Depolarizing skeletal muscle relaxants

51 citations96
US5885998AMar 23, 1999

Methods for prevention and treatment of attention deficit disorder

28 citations92
US5731314AMar 24, 1998

Pharamceutical compositions for prevention and treatment of tourette's syndrome

29 citations92
US6107298AAug 22, 2000

Methods for prevention and treatment of Tourette's syndrome and schizophrenia

13 citations74
US6100269AAug 8, 2000

Pharmaceutical compositions for prevention and treatment of central nervous system disorders

5 citations74
US5922723AJul 13, 1999

Pharmaceutical compositions for prevention and treatment of central nervous system disorders

9 citations74
US5559124ASep 24, 1996

Depolarizing skeletal muscle relaxants

14 citations73

ATACAMA THERAPEUTICS INC

3 patents

BENCHERIF MEROUANE

2 patents

MED COLLEGE GEORGIA RES INST

1 patent